Usability and Feasibility of an HIV POC Viral Load to Identify Infants at High Risk of MTCT at Birth in Primary Healthcare Clinics in Mozambique

International Workshop on HIV Pediatrics 2021

Key Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium

International Workshop on HIV Pediatrics 2021

Determinants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho

International Workshop on HIV Pediatrics 2021

Increased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed

International Workshop on HIV Pediatrics 2021

Growth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi

International Workshop on HIV Pediatrics 2021

There is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania

International Workshop on HIV Pediatrics 2021

Pediatric ARV optimization in a real-world setting: Dolutegravir transition in Mozambique

International Workshop on HIV Pediatrics 2021

Co-trimoxazole prophylaxis for children born to mothers with HIV: predicted impact of different strategies on mortality up to the age of two years

International Workshop on HIV Pediatrics 2021

Risk factors for post-discharge mortality following hospitalization for severe acute malnutrition in Zimbabwe and Zambia

International Workshop on HIV Pediatrics 2021

Estimated prevalence of prior HIV diagnosis among children living with HIV in Eswatini, Lesotho, Malawi, Tanzania, Zambia and Zimbabwe in the Population HIV Incidence Assessments (PHIA)

International Workshop on HIV Pediatrics 2021

A Costing Analysis of Index-Linked HIV Testing for Children and Adolescents in Zimbabwe

International Workshop on HIV Pediatrics 2021

Rapid antiretroviral NNRTI-based initiation among youth living with HIV outcomes in the National AIDS program in Thailand

International Workshop on HIV Pediatrics 2021

Optimizing antiretroviral treatment and viral suppression for adolescents and young people living with HIV by implementing Operation Triple Zero (OTZ) in four states in Nigeria

International Workshop on HIV Pediatrics 2021

Projecting life expectancy for youth with non-perinatally- and perinatally-acquired HIV in the United States

International Workshop on HIV Pediatrics 2021

Hospitalisation rates for youth living with perinatally acquired HIV transitioning to adult care

International Workshop on HIV Pediatrics 2021

Increasing Capacity to Detect Neurocognitive Impairment among Adolescents and Young Adults with Perinatally Acquired HIV in Thailand: Validity of the NeuorScreen tablet application.

International Workshop on HIV Pediatrics 2021

Development of a transition readiness score for adolescents living with perinatally-acquired HIV and transitioning to adult care

International Workshop on HIV Pediatrics 2021

Strategies used in countries with successful mother-infant pair tracking

International Workshop on HIV Pediatrics 2021

Participatory PMTCT: community engagement for co-created PMTCT programming in 2 districts of Zimbabwe

International Workshop on HIV Pediatrics 2021

Population-level risk factors for vertical transmission of HIV within the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis

International Workshop on HIV Pediatrics 2021

Risk factors for adverse pregnancy outcomes among pregnancy women living with HIV on ART

International Workshop on HIV Pediatrics 2021

Barriers to Early Infant Diagnosis (EID) at different stages of infancy

International Workshop on HIV Pediatrics 2021

Pregnancy characteristics and outcomes among migrant women living with HIV recently arrived in the UK

International Workshop on HIV Pediatrics 2021

Factors Associated with Recent HIV Infection Among Pregnant Women in Lilongwe, Malawi: A Case Control Study

International Workshop on HIV Pediatrics 2021